Atıf Formatları
Efficacy of tenofovir and entecavir in patients who relapsed after pegylated interferon therapy
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Ş. Kose Et Al. , "Efficacy of tenofovir and entecavir in patients who relapsed after pegylated interferon therapy," JOURNAL OF CHEMOTHERAPY , vol.31, no.4, pp.209-213, 2019

Kose, Ş. Et Al. 2019. Efficacy of tenofovir and entecavir in patients who relapsed after pegylated interferon therapy. JOURNAL OF CHEMOTHERAPY , vol.31, no.4 , 209-213.

Kose, Ş., Kis, T. T., & Atalay, S., (2019). Efficacy of tenofovir and entecavir in patients who relapsed after pegylated interferon therapy. JOURNAL OF CHEMOTHERAPY , vol.31, no.4, 209-213.

Kose, ŞÜKRAN, Tuba Tatli Kis, And Sabri Atalay. "Efficacy of tenofovir and entecavir in patients who relapsed after pegylated interferon therapy," JOURNAL OF CHEMOTHERAPY , vol.31, no.4, 209-213, 2019

Kose, ŞÜKRAN Et Al. "Efficacy of tenofovir and entecavir in patients who relapsed after pegylated interferon therapy." JOURNAL OF CHEMOTHERAPY , vol.31, no.4, pp.209-213, 2019

Kose, Ş. Kis, T. T. And Atalay, S. (2019) . "Efficacy of tenofovir and entecavir in patients who relapsed after pegylated interferon therapy." JOURNAL OF CHEMOTHERAPY , vol.31, no.4, pp.209-213.

@article{article, author={ŞÜKRAN KÖSE Et Al. }, title={Efficacy of tenofovir and entecavir in patients who relapsed after pegylated interferon therapy}, journal={JOURNAL OF CHEMOTHERAPY}, year=2019, pages={209-213} }